Inventor
KAWAI MEGUMI
US26 patents
⚠️ This page may combine multiple inventors who share the name “KAWAI MEGUMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
23 patentsUS5457111AOct 10, 1995
Macrocyclic immunomodulators
ABBOTT LAB160 citations97
US7772231B2Aug 10, 2010
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors
ABBOTT LAB68 citations95
US6323228B1Nov 27, 2001
3-substituted indole angiogenesis inhibitors
ABBOTT LAB76 citations95
US7030262B2Apr 18, 2006
3-Amino-2-hydroxyalkanoic acids and their prodrugs
ABBOTT LAB42 citations92
US5708002AJan 13, 1998
Macrocyclic immunomodulators
ABBOTT LAB26 citations92
US5541189AJul 30, 1996
Substituted aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB23 citations92
US5541193AJul 30, 1996
Heterocycle-containing macrocyclic immunomodulators
ABBOTT LAB26 citations92
US5457194AOct 10, 1995
Substituted aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB36 citations92
US7491718B2Feb 17, 2009
Sulfonamides having antiangiogenic and anticancer activity
ABBOTT LAB35 citations90
US6242494B1Jun 5, 2001
Substituted β-amino acid inhibitors of methionine aminopeptidase-2
ABBOTT LAB47 citations90
US6887863B2May 3, 2005
Hydrazide and alkoxyamide angiogenesis inhibitors
ABBOTT LAB32 citations89
US6121257ASep 19, 2000
Sulfamate containing macrocyclic immunomodulators
ABBOTT LAB18 citations84
US5561228AOct 1, 1996
Macrocyclic immunomodulators
ABBOTT LAB20 citations84
US5561140AOct 1, 1996
Substituted alicyclic amine-containing macrocyclic immunomodulators
ABBOTT LAB16 citations74
US5561139AOct 1, 1996
Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB6 citations74
US5530119AJun 25, 1996
Substituted alicyclic amine-containing macrocyclic immunomodulators
ABBOTT LAB8 citations74
US5530120AJun 25, 1996
Substituted alicyclic aliphatic-amine containing macrocyclic immunomodulators
ABBOTT LAB9 citations74
US6849757B2Feb 1, 2005
Antiangiogenic drug to treat cancer, arthritis and retinopathy
ABBOTT LAB9 citations73
US6632961B1Oct 14, 2003
Antiangiogenic drug to treat cancer, arthritis and retinopathy
ABBOTT LAB12 citations73
US5387671AFeb 7, 1995
Hexa- and heptapeptide anaphylatoxin-receptor ligands
ABBOTT LAB10 citations73
US5386011AJan 31, 1995
Hexapeptide anaphylatoxin-receptor ligands
ABBOTT LAB13 citations73
US5190922AMar 2, 1993
Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
ABBOTT LAB12 citations73
US5223485AJun 29, 1993
Anaphylatoxin-receptor ligands
ABBOTT LAB18 citations72